BVS CIK: 1665988

Bioventus Inc.

  • United States
  • Healthcare
  • MedTech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
billions USD
FY21:
0.26
FY22:
0.27
FY23:
0.27
FY24:
0.28
FY25:
0.27
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.96
FY22:
1.10
FY23:
0.54
FY24:
0.45
FY25:
0.41
Total assets
Change from FY21 to FY25
billions USD
FY21:
1.23
FY22:
1.37
FY23:
0.81
FY24:
0.73
FY25:
0.68

Liabilities & Equity

(negative)
Change from FY21 to FY25
billions USD
FY21:
0.18
FY22:
0.30
FY23:
0.18
FY24:
0.21
FY25:
0.16
(negative)
Change from FY21 to FY25
billions USD
FY21:
0.51
FY22:
0.66
FY23:
0.41
FY24:
0.33
FY25:
0.29
(positive)
Change from FY21 to FY25
billions USD
FY21:
0.46
FY22:
0.33
FY23:
0.17
FY24:
0.15
FY25:
0.18

All amounts in billions USD Data source:SEC EDGAR